Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

["Prophylactic" video-laparoscopic cholecystectomy]

F Boltri1, L Moro, P Voghera

  • 1I Divisione di Chirurgia Generale, Ospedale G. Bosco, Torino.

Minerva Chirurgica
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.

Oncogenesis·2026
Same author

Cognition and gut microbiota in schizophrenia spectrum and mood disorders: A systematic review.

Neuroscience and biobehavioral reviews·2024
Same author

Pola-R-CHP for frontline therapy in DLBCL: Are we saving money by spending more?

British journal of haematology·2023
Same author

Socio-economic inequalities in the use of drugs for the treatment of chronic diseases in Italy.

International journal for equity in health·2022
Same author

Methylene blue MMX® tablets for chromoendoscopy. Bioavailability, colon staining and safety in healthy volunteers undergoing a full colonoscopy.

Contemporary clinical trials·2018
Same author

Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction.

Critical reviews in clinical laboratory sciences·2016
Same journal

Unexpected evolution of COVID-19 in a heart transplant patient with multimorbidity recently submitted to thoracic surgery.

Minerva chirurgica·2020
Same journal

Ongoing clinical trials on axillary management.

Minerva chirurgica·2020
Same journal

Axillary management after neoadjuvant treatment.

Minerva chirurgica·2020
Same journal

Axillary observation alone versus sentinel node biopsy: past, present and future perspectives.

Minerva chirurgica·2020
Same journal

Patient flow for the management of ostomy patients.

Minerva chirurgica·2020
Same journal

The management of "fragile" and suspected COVID-19 surgical patients during pandemic: an Italian single-center experience.

Minerva chirurgica·2020
See all related articles

Prophylactic videolaparoscopic cholecystectomy (VLC) is safe for transplant candidates with gallstones. This gallbladder removal procedure shows no significant differences in outcomes compared to patients without comorbidities, supporting its use in transplant protocols.

Area of Science:

  • Transplant Surgery
  • Gastroenterology
  • Minimally Invasive Surgery

Background:

  • Cholelithiasis (gallstones) can pose infection risks in transplant candidates.
  • Prophylactic gallbladder removal is considered for specific patient groups.
  • Videolaparoscopic cholecystectomy (VLC) is a standard surgical technique.

Purpose of the Study:

  • To evaluate the safety and efficacy of prophylactic videolaparoscopic cholecystectomy (VLC) in kidney and heart transplant candidates with asymptomatic cholelithiasis.
  • To determine if associated comorbidities affect VLC outcomes in this population.

Main Methods:

  • Retrospective analysis of 7 patients undergoing prophylactic VLC.
  • Patients included those with chronic renal insufficiency on dialysis or cyanogenic congenital cardiopathy.

Related Experiment Videos

  • Data compared to historical controls without significant comorbidities.

    • Main Results:

    • Prophylactic VLC was successfully performed in all 7 patients.
    • Outcomes were comparable to patients without significant comorbidities.
    • No substantial differences in complication rates were observed.

    Conclusions:

    • Prophylactic VLC is a viable and safe option for kidney and heart transplant candidates with asymptomatic cholelithiasis.
    • This approach can be integrated into pre-transplant protocols to mitigate infection risks.
    • Careful attention to technical aspects like hemorrhage and CO2 loss is crucial for optimal results.